Cerity Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.8M Buy
362,316
+20,541
+6% +$2.37M 0.05% 289
2026
Q1
$40.8M Sell
341,775
-29,644
-8% -$3.89M 0.06% 280
2025
Q4
$50.6M Buy
371,419
+31,681
+9% +$4.56M 0.07% 233
2025
Q3
$50.1M Buy
339,738
+8,024
+2% +$1.11M 0.08% 208
2025
Q2
$42.9M Sell
331,714
-49,028
-13% -$5.94M 0.08% 214
2025
Q1
$45.5M Buy
380,742
+271,513
+249% +$33.6M 0.09% 197
2024
Q4
$13.9M Sell
109,229
-5,816
-5% -$735K 0.03% 401
2024
Q3
$15.5M Buy
115,045
+21,464
+23% +$2.87M 0.03% 375
2024
Q2
$12.7M Sell
93,581
-19,132
-17% -$2.6M 0.03% 365
2024
Q1
$14.6M Buy
112,713
+65,092
+137% +$7.87M 0.04% 360
2023
Q4
$5.45M Buy
47,621
+4,537
+11% +$453K 0.02% 521
2023
Q3
$3.92M Sell
43,084
-6,133
-12% -$633K 0.02% 460
2023
Q2
$5.54M Buy
49,217
+2,394
+5% +$253K 0.02% 474
2023
Q1
$5.46M Buy
46,823
+2,074
+5% +$217K 0.01% 476
2022
Q4
$4.95M Buy
44,749
+10,798
+32% +$1.13M 0.03% 363
2022
Q3
$2.97M Sell
33,951
-839
-2% -$76.3K 0.04% 315
2022
Q2
$2.72M Buy
34,790
+30,551
+721% +$2.52M 0.03% 344
2022
Q1
$361K Buy
4,239
+579
+16% +$55.5K 0.01% 676
2021
Q4
$440K Buy
3,660
+629
+21% +$78.1K 0.01% 634
2021
Q3
$375K Sell
3,031
-23
-0.8% -$2.96K 0.01% 520
2021
Q2
$366K Sell
3,054
-282
-8% -$32.2K 0.01% 531
2021
Q1
$351K Buy
3,336
+188
+6% +$19.1K 0.01% 514
2020
Q4
$320K Buy
3,148
+355
+13% +$33.4K 0.01% 502
2020
Q3
$235K Buy
+2,793
New +$217K 0.01% 438
2020
Q1
Sell
-3,944
Closed -$311K 533
2019
Q4
$311K Sell
3,944
-14,034
-78% -$1.09M 0.02% 427
2019
Q3
$1.43M Buy
17,978
+13,906
+342% +$1.09M 0.08% 205
2019
Q2
$341K Sell
4,072
-1,373
-25% -$109K 0.02% 374
2019
Q1
$430K Sell
5,445
-17,916
-77% -$1.31M 0.03% 346
2018
Q4
$1.56M Sell
23,361
-1,612
-6% -$112K 0.1% 179
2018
Q3
$2M Buy
24,973
+418
+2% +$31.2K 0.14% 163
2018
Q2
$1.66M Buy
24,555
+16,433
+202% +$1.19M 0.12% 176
2018
Q1
$625K Buy
+8,122
New +$601K 0.05% 299

Other funds holding XYL

Cerity Partners's XYL Position: Q2 2026 in Review

Cerity Partners increased its Xylem (XYL) stake by 6% in Q2 2026, buying an estimated $2.37M and bringing the position to 362,316 shares worth $42.8M. The position accounts for 0.05% of the portfolio, ranked #289.

Cerity Partners first reported a position in XYL in Q1 2018 and has held it in 32 quarters since. The position peaked at $50.6M in Q4 2025. 1,011 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Cerity Partners held 362,316 shares of Xylem worth $42.8M as of Q2 2026.
  • Cerity Partners bought 20,541 Xylem shares in Q2 2026, an estimated $2.37M.
  • Xylem made up 0.05% of Cerity Partners's portfolio in Q2 2026, its #289 holding.
  • Cerity Partners first reported a position in Xylem in Q1 2018 and has held it in 32 quarters since.
  • Cerity Partners's Xylem position peaked at $50.6M in Q4 2025.
  • 1,011 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.